A Surface-Modified Chylomicron Remnant-like Emulsion for Percutaneous Computed Tomography Lymphography: Synthesis and Preliminary Imaging Findings
暂无分享,去创建一个
E. Wisner | R. Counsell | J. Weichert | S. Weisbrode | M. Longino | ERIK R. WISNER | JAMEY P. WEICHERT | MARC A. LONGINO | RAYMOND E. COUNSELL | STEPHEN E. WEISBRODE
[1] F. Lee,et al. Lipid-based blood-pool CT imaging of the liver. , 1998, Academic radiology.
[2] R. Counsell,et al. Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver. , 1995, Journal of medicinal chemistry.
[3] K. Ushijima,et al. Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging. , 1995, Journal of obstetrics and gynaecology.
[4] M. Prince,et al. Iron oxide‐enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer , 1997, Journal of magnetic resonance imaging : JMRI.
[5] C. Beigelman,et al. Iron oxide-enhanced MR lymphography: initial experience. , 2000, European journal of radiology.
[6] S. Griffey,et al. Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles. , 1996, Academic radiology.
[7] S. Ruehm,et al. Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: assessment in rabbits. , 2001, Radiology.
[8] F. Hilgers,et al. Computed tomography for the detection of neck node metastases in melanoma patients. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] S. Griffey,et al. Indirect computed tomography lymphography using iodinated nanoparticles: time and dose response in normal canine lymph nodes. , 1995, Academic radiology.
[10] V. Torchilin. Handbook of targeted delivery of imaging agents , 1995 .
[11] A. Sachse,et al. Interstitial Mr Lymphography Using Gd-Carrying Liposomes , 1997, Acta radiologica. Supplementum.
[12] R B Lufkin,et al. Imaging of nodal metastases in the head and neck , 1997, Journal of magnetic resonance imaging : JMRI.
[13] M. Papisov,et al. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies. , 1996, Radiology.
[14] R. Counsell,et al. Formulation of Polyiodinated Triglyceride Analogues in a Chylomicron Remnant-Like Liver-Selective Delivery Vehicle , 1996, Pharmaceutical Research.
[15] G L Wolf,et al. Lymph node extraction of radiopaque nanoparticulates in the rabbit as measured in vivo with CT. , 1999, Academic radiology.
[16] B. Persson,et al. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. , 1983, Seminars in nuclear medicine.
[17] E. Kazerooni,et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT. , 1998, AJR. American journal of roentgenology.
[18] G. Frija,et al. MR lymphography using iron oxide nanoparticles in rats: Pharmacokinetics in the lymphatic system after intravenous injection , 2000, Journal of magnetic resonance imaging : JMRI.
[19] J. Seibert,et al. Quantitative methods for indirect CT lymphography. , 1998, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[20] G. Wolf,et al. Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure. , 2000, Investigative Radiology.
[21] Y. Nishimura,et al. Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging. , 1996, International journal of radiation oncology, biology, physics.
[22] Y. Nishiwaki,et al. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer. , 2000, The Journal of thoracic and cardiovascular surgery.
[23] R. Counsell,et al. Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: effects of physicochemical properties on biodistribution and imaging profiles. , 2000, Investigative radiology.
[24] M. Nantz,et al. A modular lymphographic magnetic resonance imaging contrast agent: contrast enhancement with DNA transfection potential. , 1997, Journal of medicinal chemistry.
[25] Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid. , 2000, Biological & pharmaceutical bulletin.
[26] P. Muzzio,et al. Rectal cancer: CT local staging with histopathologic correlation , 2001, Abdominal Imaging.
[27] B. Persson,et al. Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] H. Honda,et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. , 1995, Radiology.
[29] C. Ciccotosto,et al. Lung cancer staging: the role of computed tomography and magnetic resonance imaging. , 1996, European journal of radiology.
[30] G. Schmid-Schönbein,et al. Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. , 1995, Radiology.